Henan Taloph Pharmaceutical Stock Co Ltd (600222) — Net Asset Quality Index

Latest as of March 2026: 45.3%

Henan Taloph Pharmaceutical Stock Co Ltd (600222) has a Net Asset Quality Index of 45.3% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥3.68 Billion minus total liabilities of CN¥2.01 Billion yields net assets of CN¥1.66 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read debt load of Henan Taloph Pharmaceutical Stock Co Ltd for a breakdown of total debt and financial obligations.

Quality Index

45.3%
Equity / Total Assets

Net Assets

CN¥1.66 Billion
CNY

Total Assets

CN¥3.68 Billion
CNY

Total Liabilities

CN¥2.01 Billion
CNY

Henan Taloph Pharmaceutical Stock Co Ltd Net Asset Quality Index Over Time (1996–2025)

This chart shows how Henan Taloph Pharmaceutical Stock Co Ltd's Net Asset Quality Index has evolved across 30 annual periods from 1996 to 2025. As of March 2026, the index stands at 45.3%, representing net assets of CN¥1.66 Billion against total assets of CN¥3.68 Billion CNY. For live market cap and overall valuation, see Henan Taloph Pharmaceutical Stock Co Ltd (600222) total market value.

Annual Net Asset Quality Index for Henan Taloph Pharmaceutical Stock Co Ltd (1996–2025)

The table below presents the year-by-year Net Asset Quality Index for Henan Taloph Pharmaceutical Stock Co Ltd from 1996 to 2025, covering 30 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check Henan Taloph Pharmaceutical Stock Co Ltd strategic capital allocation to assess the company's strategic physical and investment asset allocation.

Year Quality Index Net Assets (CNY) Total Assets Total Liabilities Change (pp)
2025 45.7% CN¥1.66 Billion CN¥3.64 Billion CN¥1.98 Billion ▼ -0.9 pp
2024 46.6% CN¥1.63 Billion CN¥3.49 Billion CN¥1.86 Billion ▲ +1.2 pp
2023 45.4% CN¥1.62 Billion CN¥3.58 Billion CN¥1.95 Billion ▲ +0.6 pp
2022 44.8% CN¥1.61 Billion CN¥3.60 Billion CN¥1.99 Billion ▼ -2.1 pp
2021 47.0% CN¥1.78 Billion CN¥3.78 Billion CN¥2.01 Billion ▲ +1.8 pp
2020 45.2% CN¥1.53 Billion CN¥3.39 Billion CN¥1.86 Billion ▼ -2.7 pp
2019 47.9% CN¥1.31 Billion CN¥2.74 Billion CN¥1.43 Billion ▼ -1.2 pp
2018 49.1% CN¥1.39 Billion CN¥2.84 Billion CN¥1.44 Billion ▼ -4.6 pp
2017 53.7% CN¥1.51 Billion CN¥2.81 Billion CN¥1.30 Billion ▼ -2.9 pp
2016 56.6% CN¥1.50 Billion CN¥2.65 Billion CN¥1.15 Billion ▼ -0.2 pp
2015 56.8% CN¥1.50 Billion CN¥2.64 Billion CN¥1.14 Billion ▲ +5.0 pp
2014 51.8% CN¥1.19 Billion CN¥2.29 Billion CN¥1.11 Billion ▼ -4.2 pp
2013 55.9% CN¥1.09 Billion CN¥1.95 Billion CN¥861.22 Million ▲ +14.1 pp
2012 41.8% CN¥656.50 Million CN¥1.57 Billion CN¥912.93 Million ▼ -1.2 pp
2011 43.1% CN¥628.89 Million CN¥1.46 Billion CN¥831.28 Million ▼ -5.6 pp
2010 48.7% CN¥609.32 Million CN¥1.25 Billion CN¥641.92 Million ▼ -5.0 pp
2009 53.7% CN¥586.04 Million CN¥1.09 Billion CN¥506.12 Million ▼ -5.6 pp
2008 59.3% CN¥554.97 Million CN¥936.40 Million CN¥381.43 Million ▼ -2.5 pp
2007 61.7% CN¥521.57 Million CN¥844.86 Million CN¥323.29 Million ▲ +1.6 pp
2006 60.2% CN¥487.05 Million CN¥809.29 Million CN¥322.24 Million ▼ -2.7 pp
2005 62.9% CN¥471.96 Million CN¥750.66 Million CN¥278.70 Million ▲ +1.2 pp
2004 61.7% CN¥455.68 Million CN¥739.11 Million CN¥283.44 Million ▼ -0.5 pp
2003 62.1% CN¥440.61 Million CN¥708.97 Million CN¥268.36 Million ▲ +0.3 pp
2002 61.8% CN¥428.30 Million CN¥693.00 Million CN¥264.70 Million ▼ -5.1 pp
2001 66.9% CN¥416.84 Million CN¥622.91 Million CN¥206.07 Million ▼ -4.7 pp
2000 71.6% CN¥410.41 Million CN¥572.86 Million CN¥162.45 Million ▼ -1.0 pp
1999 72.7% CN¥401.57 Million CN¥552.67 Million CN¥151.10 Million ▲ +24.2 pp
1998 48.4% CN¥154.84 Million CN¥319.63 Million CN¥164.79 Million ▲ +2.6 pp
1997 45.9% CN¥118.87 Million CN¥259.15 Million CN¥140.28 Million ▲ +8.1 pp
1996 37.8% CN¥85.11 Million CN¥225.34 Million CN¥140.23 Million
pp = percentage points